Welcome to the GSK Hub

As one of the world’s leading healthcare companies, GSK discovers, develops, manufactures and distributes life-saving vaccines, prescription medicines and consumer health products such as Maximuscle, Sensodyne, Aquafresh and Panadol. The size and scope of our organisation allows our people to answer some of the biggest questions... Read more »

Typically recruits

  • Aerospace
  • Chemical/Process
  • Civil/Building
  • Computing/Technology
  • Electronic & Electrical
  • Materials & Minerals
  • Mechanical/Manufacturing
  • Sciences/Maths

We sponsor the Technology - Healthcare sector
in the 2018/19 Gradcracker Toolkit

Headquartered in the UK, a global organisation with offices in over 100 countries.
Our business employs over 97,000 people in over 100 countries.
Around 12,500 people work in our research teams in the UK, USA, Spain, Belgium and China.
Our products include Maximuscle, Sensodyne, Aquafresh and Panadol.
Over 7,000 students have Followed us on Gradcracker.
A Gradcracker advertiser for at least five years - ideal for your shortlist!

Hui

Materials Science Graduate

"I’ve worked on one of the world’s best known brands, Horlicks, contributing to changing manufacturing processes"

Read more

Charlotte

Medicinal Chemist

"Career progression here is directly related to your contribution, rather than just qualifications. You get out what you put in."

Read more

My Summer as a Process Engineering Internship Student at GSK!

Carol Nairn is a Chemical Engineering student at the University of Strathclyde. Since early June, she has been working as a Process Engineering Internship Student at the GlaxoSmithKline Irvine site and took some time out to tell us all about it! I’m a Chemical (& Process, but we...

Read more

GlaxoSmithKline Confirms Plans To Create Up to 1000 Jobs

In total more than £500m of investment confirmed, creating up to 1,000 new jobs Includes £100m investment for GSK manufacturing in Scotland Options for further significant investment in UK manufacturing also under consideration GSK has announced recently that it is...

Read more